News | April 06, 2026
Samsung Biologics lands first US manufacturing facility with GSK acquisition
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Board approves five-year appointment, subject to shareholder nod through postal ballot
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
Subscribe To Our Newsletter & Stay Updated
